Insider · CIK 0001995218
Richard Nolan Townsend
ceoofficerdirector
Files at LXEO (Lexeo Therapeutics, Inc.). First filing Oct 15, 2024, latest Feb 20, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 9
$0 bought, $294k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LXEO: Lexeo Therapeutics, Inc.
LXEOOct 9, 2026 · close 3.23
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Lexeo Therapeutics, Inc. | $65k 10,173 shares | -3% | +251% from low-41% from high | |
| 40Moderate | Lexeo Therapeutics, Inc. | $10k 1,127 shares | -0% | +413% from low-9% from high | |
| 50Moderate | Lexeo Therapeutics, Inc. | $117k 13,133 shares | -5% | +435% from low-14% from high | |
| 40Moderate | Lexeo Therapeutics, Inc. | $5,205 1,115 shares | -1% | +175% from low-56% from high | |
| 40Moderate | Lexeo Therapeutics, Inc. | $13k 2,735 shares | -1% | +175% from low-56% from high | |
| 40Moderate | Lexeo Therapeutics, Inc. | $2,979 1,074 shares | -0% | +81% from low-71% from high | |
| 0Weak | Lexeo Therapeutics, Inc. | $20k 2,500 shares | -2% | - | |
| 0Weak | Lexeo Therapeutics, Inc. | $20k 2,500 shares | -2% | - | |
| 0Weak | Lexeo Therapeutics, Inc. | $40k 5,000 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +2,306 | $2.64 | $6,097 | 376,778 | 14 d ago |
| Sep 24, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +145,500 | $0.00 | $0 | 145,500 | 14 d ago |
| Mar 13, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +2,623 | $2.64 | $6,935 | 395,106 | Mar 17, 2026 |
| Feb 18, 2026 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -10,173 | $6.38 | $65k | 392,483 | Feb 20, 2026 |
| Feb 4, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +161,665 | $0.00 | $0 | 402,656 | Feb 6, 2026 |
| Feb 4, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +646,665 | $0.00 | $0 | 646,665 | Feb 6, 2026 |
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -1,127 | $9.27 | $10k | 240,991 | Nov 20, 2025 |
| Oct 15, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +33,000 | $0.00 | $0 | 255,251 | Oct 17, 2025 |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -12,985 | $8.94 | $116k | 242,266 | Oct 17, 2025 |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -148 | $9.56 | $1,415 | 242,118 | Oct 17, 2025 |
| Sep 12, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +2,193 | $2.64 | $5,798 | 222,251 | Sep 16, 2025 |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -1,115 | $4.67 | $5,205 | 220,058 | Sep 10, 2025 |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -2,735 | $4.67 | $13k | 220,058 | Aug 20, 2025 |
| May 16, 2025 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock | -1,074 | $2.77 | $2,979 | 221,173 | May 20, 2025 |
| Mar 14, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Common Stock | +2,128 | $2.61 | $5,554 | 222,247 | Apr 1, 2025 |
| Dec 10, 2024 | LXEO Lexeo Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,500 | $2.33 | $5,825 | 123,195 | Dec 12, 2024 |
| Dec 10, 2024 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,500 | $8.20 | $20k | 120,695 | Dec 12, 2024 |
| Dec 10, 2024 | LXEO Lexeo Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 118,655 | Dec 12, 2024 |
| Nov 11, 2024 | LXEO Lexeo Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,500 | $2.33 | $5,825 | 123,195 | Nov 13, 2024 |
| Nov 11, 2024 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,500 | $7.82 | $20k | 120,695 | Nov 13, 2024 |
| Nov 11, 2024 | LXEO Lexeo Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 121,155 | Nov 13, 2024 |
| Oct 10, 2024 | LXEO Lexeo Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | $2.33 | $12k | 125,695 | Oct 15, 2024 |
| Oct 10, 2024 | LXEO Lexeo Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $8.10 | $40k | 120,695 | Oct 15, 2024 |
| Oct 10, 2024 | LXEO Lexeo Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 123,655 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.